Literature DB >> 16470251

Internet-based asthma education - a novel approach to compliance: a case report.

Cindy O'Hara1, Dilini Vethanayagam, Carina Majaesic, Irvin Mayers.   

Abstract

Asthma costs Canadians over 1.2 billion dollars per annum and, despite advances, many asthmatic patients still have poor control. An action plan, symptom diary and measurement of peak expiratory flow have been shown to improve clinical outcomes. Effective educational interventions are an important component of good care. However, many rural sites lack not only access to education but physician care as well. It is reasonable, therefore, that an Internet-based asthma management program may be used as an approach. In the present case report, a novel approach that may increase access in these poorly serviced areas is presented. In an Internet-based asthma management program, patients are reviewed by a physician, receive education and are given a unique password that provides program access. Patients record symptoms and peak expiratory flow rates. The present case report shows that a patient can be assisted through an exacerbation, thus averting emergency intervention and stabilizing control, even when travelling on another continent.

Entities:  

Mesh:

Year:  2006        PMID: 16470251      PMCID: PMC2539009          DOI: 10.1155/2006/435028

Source DB:  PubMed          Journal:  Can Respir J        ISSN: 1198-2241            Impact factor:   2.409


  8 in total

1.  Factors associated with hospital admissions and repeat emergency department visits for adults with asthma.

Authors:  R J Adams; B J Smith; R E Ruffin
Journal:  Thorax       Date:  2000-07       Impact factor: 9.139

2.  The effect of a peak flow-based action plan in the prevention of exacerbations of asthma.

Authors:  R L Cowie; S G Revitt; M F Underwood; S K Field
Journal:  Chest       Date:  1997-12       Impact factor: 9.410

3.  Are asthma medications and management related to deaths from asthma?

Authors:  M J Abramson; M J Bailey; F J Couper; J S Driver; O H Drummer; A B Forbes; J J McNeil; E Haydn Walters
Journal:  Am J Respir Crit Care Med       Date:  2001-01       Impact factor: 21.405

4.  What is new since the last (1999) Canadian Asthma Consensus Guidelines?

Authors:  L P Boulet; T R Bai; A Becker; D Bérubé; R Beveridge; D M Bowie; K R Chapman; J Côté; D Cockcroft; F M Ducharme; P Ernst; J M FitzGerald; T Kovesi; R V Hodder; P O'Byrne; B Rowe; M R Sears; F E Simons; S Spier
Journal:  Can Respir J       Date:  2001 Mar-Apr       Impact factor: 2.409

Review 5.  The costs of asthma.

Authors:  P J Barnes; B Jonsson; J B Klim
Journal:  Eur Respir J       Date:  1996-04       Impact factor: 16.671

6.  An evaluation of the quality and contents of asthma education on the World Wide Web.

Authors:  Donita R Croft; Michael W Peterson
Journal:  Chest       Date:  2002-04       Impact factor: 9.410

7.  A qualitative study of action plans for asthma.

Authors:  Jo Douglass; Rosalie Aroni; Dianne Goeman; Kay Stewart; Susan Sawyer; Frank Thien; Michael Abramson
Journal:  BMJ       Date:  2002-04-27

8.  Direct and indirect costs of asthma in Canada, 1990.

Authors:  M D Krahn; C Berka; P Langlois; A S Detsky
Journal:  CMAJ       Date:  1996-03-15       Impact factor: 8.262

  8 in total
  3 in total

1.  The efficacy of tiotropium as a steroid-sparing agent in severe asthma.

Authors:  Anmol S Kapoor; Sharla-Rae Olsen; Cindy O'Hara; Lakshmi Puttagunta; Dilini Vethanayagam
Journal:  Can Respir J       Date:  2009 May-Jun       Impact factor: 2.409

2.  The effectiveness of telegram-based virtual education versus in-person education on the quality of life in adolescents with moderate-to-severe asthma: A pilot randomized controlled trial.

Authors:  Shiva Faraji; Sousan Valizadeh; Akbar Sharifi; Shahla Shabazi; Morteza Ghojazadeh
Journal:  Nurs Open       Date:  2020-06-28

3.  Assessing compliance: active versus inactive trainees in a memory intervention.

Authors:  Dana K Bagwell; Robin L West
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.